Morgan Stanley Downgrades Mindray Medical To Underweight

MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO

As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.

Analysts at Morgan Stanley downgraded Mindray Medical International (NYSE: MR) from Equal-weight to Underweight. The price target for Mindray Medical has been lowered from $37 to $28. Mindray Medical shares have declined 24.02% over the past 52 weeks, while the S&P 500 index has gained 14.65% in the same period. Mindray Medical's shares fell 0.28% to close at $28.19 yesterday.

MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO

As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!